focus -WSS

focus

author：fashion 2025-09-28 23:48:27 - browse：933

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： UnitedHealth argues against case alleging wrongful AI care denials

WSS

Scrutiny of post

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Home health providers sue Medicare over payment cuts

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Listen: More tumult at BIO & coercive care for sickle cell patients

leisure time

focus

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

23andMe had bad news about my health. I wish a person had delivered it

White House announces new plan to address the growing threat of xylazine in overdose crisis

Novavax promises a turnaround & Lilly roils the obesity market

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Medical leaders decry Supreme Court decision on affirmative action

Eisai exec who led development of Alzheimer’s drug to retire

In Memoriam: Notable people who died in 2023

Bird flu surveillance in wastewater gets boost from consortium

focus

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Addressing health care workers' trauma can help fight burnout

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Teachers share how revamped forgiveness program helped with their student loans

Medicare wants to send $9 billion to 340B hospitals

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Wikipedia

hotspot

entertainment

leisure time